HER-88417-63980
4 vaccinations
6 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 900 / CA
- Registered
- 2021-12-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-12-20
Dose 3 — Pfizer-BioNTech
-
2021-12-21
Registered in v-safe
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-28
Survey response — day 7, dose 3MedDRA: Eye inflammation, Urinary tract infection — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: UTI, eye inflammationMedDRA releases: 2024-11 · check-in free text available
- 2022-01-03
-
2022-01-12
Survey response — day 21, dose 3MedDRA: Myalgia, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to do your normal daily activitiesFree text: Muscle pain, running nose, sneezeMedDRA releases: 2024-11 · check-in free text available
- 2022-01-18
- 2022-01-25
- 2022-01-31
- 2022-03-21
-
2022-06-20
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I caught COVID-19.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-20
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-21
-
2022-12-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-12-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-18
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-19
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-21
Health check-in — day 7, dose 4Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-12-28
- 2023-01-04
-
2023-01-13
Survey response — day 28, dose 4MedDRA: Fatigue, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-01-18
Survey response — day 35, dose 4MedDRA: Cough, Fatigue, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-03-15
-
2023-06-14
Survey response — 6 months, dose 4MedDRA: Headache, Nasal congestion, Oropharyngeal pain — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | No |
| 2 | 2021-04-30 | Pfizer-BioNTech | No |
| 3 | 2021-12-20 | Pfizer-BioNTech | No |
| 4 | 2022-12-14 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 7, dose 3
Systemic reaction (other): UTI, eye inflammation
Release 10 — day 21, dose 3
Symptoms: Muscle pain, running nose, sneeze
Release 12 — 6 months, dose 3
Symptoms: I caught COVID-19.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Eye inflammation | · | · | ✓ |
| SRO | Urinary tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release